What is the current annual ROE of GSK?

As of today, GSK annual ROE is 43.79%

What is 1-year change in GSK annual ROE?

GSK annual ROE is up +89.90% year-over-year

What is 3-year change in GSK annual ROE?

GSK annual ROE is up +48.29% over the past 3 years

How far is GSK annual ROE from its all-time high?

GSK annual ROE is currently -82.82% below its historical high of 254.91% set on December 31, 1996

How does GSK annual ROE rank versus sector peers?

GSK annual ROE is higher than 89.11% of companies in Healthcare sector

When is GSK next annual earnings release?

As of today, the next annual earnings release for GSK has not been scheduled

What is the current quarterly ROE of GSK?

As of today, GSK quarterly ROE is 41.45%

What is GSK quarterly ROE most recent change?

GSK quarterly ROE was down -3.63% on March 31, 2026

What is 1-year change in GSK quarterly ROE?

GSK quarterly ROE is up +55.19% year-over-year

How far is GSK quarterly ROE from its all-time high?

GSK quarterly ROE is currently -83.73% below its historical high of 254.79% set on September 30, 1995

How does GSK quarterly ROE rank versus sector peers?

GSK quarterly ROE is higher than 87.80% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on July 29, 2026

GSK Plc (GSK) ROE History & Chart Since 1986

Annual ROE

43.79%20.73%+89.90%

December 31, 2025

Summary

Current Value: As of today, GSK annual ROE is 43.79%, up +89.90% on December 31, 2025
Historical Performance: GSK annual ROE is up +48.29% over the past 3 years, up +41.03% over the past 5 years
All-Time High Comparison: GSK annual ROE is currently -82.82% below its historical high of 254.91% set on December 31, 1996
3-Year Low Comparison: GSK annual ROE is +89.90% above its 3-year low of 23.06% reached on December 31, 2024
Sector Comparison: GSK annual ROE is higher than 89.11% of companies in Healthcare sector

ROE Chart

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual ROE	Dec 31, 25	43.79%	+89.9%	+48.3%	+41.0%	+149.7%
Quarterly ROE	Mar 31, 26	41.45%	+55.2%	+10.7%	+43.8%	+102.0%
Price	May 13, 26	$51.01	+40.3%	+39.6%	+29.4%	+14.4%
PE Ratio	May 13, 26	13.34	-29.3%	+210.2%	+14.1%	-57.6%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%
Annual Net Income	Dec 31, 25	$8.29B	+119.8%	+36.7%	+1.2%	+189.8%
Annual Shareholders Equity	Dec 31, 25	$22.03B	+28.7%	+72.8%	+10.5%	+58.3%
Annual ROA	Dec 31, 25	10.58%	+109.9%	+56.7%	+39.2%	+150.1%

ROE Highs

GSK Annual ROE Highs Comparison
Period	High	Date	Current
3Y	46.37%	Dec 31, 23	-5.6%
5Y	46.37%	Dec 31, 23	-5.6%
All	254.91%	Dec 31, 96	-82.8%

ROE Lows

GSK Annual ROE Lows Comparison
Period	Low	Date	Current
3Y	23.06%	Dec 31, 24	+89.9%
5Y	16.86%	Dec 31, 21	+159.7%
All	14.87%	Dec 31, 16	+194.5%

ROE History

Year	Value	Change
2025	43.79%	+89.9%
2024	23.06%	-50.3%
2023	46.37%	+57.0%
2022	29.53%	+75.1%
2021	16.86%	-45.7%
2020	31.05%	-33.0%
2019	46.36%	-59.6%
2018	114.83%	+123.1%
2017	51.48%	+246.2%
2016	14.87%	-87.9%
2015	123.10%	+172.5%
2014	45.18%	-38.8%
2013	73.79%	+22.8%
2012	60.10%	-0.5%
2011	60.39%	+244.3%
2010	17.54%	-71.1%
2009	60.72%	+10.9%
2008	54.74%	-0.6%
2007	55.05%	-13.3%
2006	63.50%	-11.5%

Year	Value	Change
2005	71.75%	+5.1%
2004	68.25%	-20.2%
2003	85.54%	+7.6%
2002	79.52%	+54.3%
2001	51.53%	-28.6%
2000	72.21%	-5.1%
1999	76.11%	-5.0%
1998	80.08%	-31.3%
1997	116.64%	-54.2%
1996	254.91%	+560.4%
1995	38.60%	+46.7%
1994	26.32%	-6.4%
1993	28.11%	-5.9%
1992	29.88%	-6.7%
1991	32.01%	+3.3%
1990	31.00%	-12.5%
1989	35.43%	-5.4%
1988	37.47%	-2.7%
1987	38.50%	-8.0%
1986	41.85%	-

FAQ

What is the current annual ROE of GSK?
As of today, GSK annual ROE is 43.79%
What is 1-year change in GSK annual ROE?
GSK annual ROE is up +89.90% year-over-year
What is 3-year change in GSK annual ROE?
GSK annual ROE is up +48.29% over the past 3 years
How far is GSK annual ROE from its all-time high?
GSK annual ROE is currently -82.82% below its historical high of 254.91% set on December 31, 1996
How does GSK annual ROE rank versus sector peers?
GSK annual ROE is higher than 89.11% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled

Quarterly ROE

41.45%1.56%-3.63%

March 31, 2026

Summary

Current Value: As of today, GSK quarterly ROE is 41.45%, down -3.63% on March 31, 2026
Historical Performance: GSK quarterly ROE is up +55.19% year-over-year, up +10.71% over the past 3 years
All-Time High Comparison: GSK quarterly ROE is currently -83.73% below its historical high of 254.79% set on September 30, 1995
3-Year Low Comparison: GSK quarterly ROE is +93.42% above its 3-year low of 21.43% reached on September 30, 2024
Sector Comparison: GSK quarterly ROE is higher than 87.80% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly ROE	Mar 31, 26	41.45%	-3.6%	+55.2%	+10.7%	+43.8%
Annual ROE	Dec 31, 25	43.79%	–	+89.9%	+48.3%	+41.0%
Price	May 13, 26	$51.01	-13.4%	+40.3%	+39.6%	+29.4%
PE Ratio	May 13, 26	13.34	-17.0%	-29.3%	+210.2%	+14.1%
Quarterly Revenue	Mar 31, 26	$10.28B	-10.3%	+8.6%	+21.7%	+0.5%
Quarterly Net Income	Mar 31, 26	$2.48B	+156.3%	+11.0%	+25.0%	+42.6%
Quarterly Shareholders Equity	Mar 31, 26	$23.54B	+6.9%	+28.8%	+61.1%	+14.8%
Quarterly ROA	Mar 31, 26	10.48%	+0.9%	+72.1%	+46.0%	+44.4%

Quarterly ROE Highs

GSK Quarterly ROE Highs Comparison
Period	High	Date	Current
1Y	43.01%	Dec 31, 25	-3.6%
3Y	60.05%	Sep 30, 23	-31.0%
5Y	60.05%	Sep 30, 23	-31.0%
All	254.79%	Sep 30, 95	-83.7%

Quarterly ROE Lows

GSK Quarterly ROE Lows Comparison
Period	Low	Date	Current
1Y	26.71%	N/A	+55.2%
3Y	21.43%	Sep 30, 24	+93.4%
5Y	18.50%	Dec 31, 21	+124.0%
All	1.24%	Jun 30, 16	+3242.7%

Quarterly ROE History

Month	Value	Change
Mar 2026	41.45%	-3.6%
Dec 2025	43.01%	+0.4%
Sep 2025	42.84%	+48.1%
Jun 2025	28.92%	+8.3%
Mar 2025	26.71%	+21.1%
Dec 2024	22.05%	+2.9%
Sep 2024	21.43%	-36.1%
Jun 2024	33.53%	-12.8%
Mar 2024	38.46%	-14.6%
Dec 2023	45.03%	-25.0%
Sep 2023	60.05%	+35.4%
Jun 2023	44.34%	+18.4%
Mar 2023	37.44%	+11.8%
Dec 2022	33.49%	+52.0%
Sep 2022	22.04%	+9.6%
Jun 2022	20.11%	-12.9%
Mar 2022	23.10%	+24.9%
Dec 2021	18.50%	-10.6%
Sep 2021	20.69%	-11.2%
Jun 2021	23.31%	-19.1%
Mar 2021	28.83%	-8.3%
Dec 2020	31.45%	-13.7%
Sep 2020	36.46%	-21.0%
Jun 2020	46.14%	-2.8%
Mar 2020	47.46%	-15.8%
Dec 2019	56.37%	-29.8%
Sep 2019	80.34%	-44.5%
Jun 2019	144.64%	+19.2%
Mar 2019	121.37%	+5.7%
Dec 2018	114.80%	+80.5%
Sep 2018	63.61%	+8.5%
Jun 2018	58.63%	+48.4%
Mar 2018	39.51%	-13.5%
Dec 2017	45.70%	-22.9%
Sep 2017	59.29%	+19.1%
Jun 2017	49.77%	+40.2%
Mar 2017	35.51%	+107.1%
Dec 2016	17.15%	+421.3%
Sep 2016	3.29%	+165.3%
Jun 2016	1.24%	-83.0%
Mar 2016	7.29%	-92.1%
Dec 2015	92.52%	-19.9%
Sep 2015	115.47%	-1.4%
Jun 2015	117.14%	-12.8%
Mar 2015	134.33%	+212.6%
Dec 2014	42.97%	-30.7%
Sep 2014	62.01%	-8.9%
Jun 2014	68.07%	-5.8%
Mar 2014	72.26%	-6.8%
Dec 2013	77.55%	+41.0%
Sep 2013	54.99%	-2.6%
Jun 2013	56.43%	+1.2%
Mar 2013	55.76%	-4.3%
Dec 2012	58.29%	-6.0%
Sep 2012	62.04%	+0.2%
Jun 2012	61.94%	+7.7%
Mar 2012	57.53%	-4.4%
Dec 2011	60.16%	+59.1%
Sep 2011	37.82%	+6.1%
Jun 2011	35.64%	+73.7%
Mar 2011	20.52%	+15.3%
Dec 2010	17.79%	-56.3%
Sep 2010	40.72%	-6.5%
Jun 2010	43.55%	-30.5%
Mar 2010	62.62%	-2.1%
Dec 2009	63.97%	+9.4%
Sep 2009	58.49%	+3.7%
Jun 2009	56.43%	+3.7%
Mar 2009	54.40%	-1.6%
Dec 2008	55.29%	+3.4%
Sep 2008	53.46%	+1.3%
Jun 2008	52.79%	+3.8%
Mar 2008	50.88%	-2.7%
Dec 2007	52.31%	-3.1%
Sep 2007	53.99%	-3.6%
Jun 2007	56.01%	-4.6%
Mar 2007	58.68%	-4.9%
Dec 2006	61.73%	-4.3%
Sep 2006	64.50%	-2.7%

Month	Value	Change
Jun 2006	66.32%	-5.8%
Mar 2006	70.37%	-2.7%
Dec 2005	72.32%	+0.0%
Sep 2005	72.31%	-3.6%
Jun 2005	75.01%	-4.8%
Mar 2005	78.79%	+3.3%
Dec 2004	76.24%	-1.3%
Sep 2004	77.27%	+9.1%
Jun 2004	70.82%	+4.9%
Mar 2004	67.52%	-2.0%
Dec 2003	68.92%	+0.5%
Sep 2003	68.55%	+12.4%
Jun 2003	60.98%	+2.2%
Mar 2003	59.64%	-1.7%
Dec 2002	60.67%	+14.1%
Sep 2002	53.19%	+16.3%
Jun 2002	45.75%	+7.0%
Mar 2002	42.75%	+9.9%
Dec 2001	38.89%	-10.2%
Sep 2001	43.30%	-12.2%
Jun 2001	49.32%	-0.4%
Mar 2001	49.54%	-15.4%
Dec 2000	58.56%	+17.9%
Sep 2000	49.69%	-8.8%
Jun 2000	54.46%	-7.1%
Mar 2000	58.60%	-15.0%
Dec 1999	68.94%	+4.8%
Sep 1999	65.77%	-22.9%
Jun 1999	85.26%	+12.6%
Mar 1999	75.70%	-27.3%
Dec 1998	104.10%	+25.2%
Sep 1998	83.18%	+11.8%
Jun 1998	74.37%	-19.7%
Mar 1998	92.62%	+30.8%
Dec 1997	70.79%	-60.7%
Sep 1997	180.15%	+15.3%
Jun 1997	156.25%	+1.3%
Mar 1997	154.23%	+142.4%
Dec 1996	63.62%	-74.8%
Mar 1996	252.77%	-0.8%
Sep 1995	254.79%	+761.7%
Jun 1995	29.57%	+40.5%
Mar 1995	21.05%	-3.9%
Dec 1994	21.91%	-6.5%
Sep 1994	23.44%	-22.5%
Jun 1994	30.24%	+7.3%
Mar 1994	28.19%	-2.8%
Dec 1993	28.99%	+3.9%
Sep 1993	27.89%	-16.7%
Jun 1993	33.48%	+26.2%
Mar 1993	26.53%	+1.5%
Dec 1992	26.13%	-0.2%
Sep 1992	26.19%	-29.7%
Jun 1992	37.28%	+0.8%
Mar 1992	37.00%	+5.1%
Dec 1991	35.21%	+5.4%
Sep 1991	33.42%	-21.3%
Jun 1991	42.49%	+36.4%
Mar 1991	31.14%	+3.0%
Dec 1990	30.23%	+3.2%
Sep 1990	29.30%	-32.5%
Jun 1990	43.43%	+14.1%
Mar 1990	38.07%	+8.6%
Dec 1989	35.07%	+3.7%
Sep 1989	33.83%	-22.1%
Jun 1989	43.41%	+14.5%
Mar 1989	37.91%	+2.7%
Dec 1988	36.93%	+4.3%
Sep 1988	35.40%	-19.4%
Jun 1988	43.94%	+8.3%
Mar 1988	40.57%	+1.5%
Dec 1987	39.99%	+7.6%
Sep 1987	37.18%	+8.6%
Jun 1987	34.25%	-18.5%
Mar 1987	42.03%	+9.6%
Dec 1986	38.34%	+3.1%
Sep 1986	37.20%	+5.5%
Jun 1986	35.27%	-

FAQ

What is the current quarterly ROE of GSK?
As of today, GSK quarterly ROE is 41.45%
What is GSK quarterly ROE most recent change?
GSK quarterly ROE was down -3.63% on March 31, 2026
What is 1-year change in GSK quarterly ROE?
GSK quarterly ROE is up +55.19% year-over-year
How far is GSK quarterly ROE from its all-time high?
GSK quarterly ROE is currently -83.73% below its historical high of 254.79% set on September 30, 1995
How does GSK quarterly ROE rank versus sector peers?
GSK quarterly ROE is higher than 87.80% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on July 29, 2026

ROE Formula

ROE = Net Income

Shareholders Equity × 100%

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk